After 3 days of Ang II infusion, the proportions of the developed aneurysms were as follows for SDC-1+/+ and SDC-1−/− mice respectively: TAA (40 vs. 35%), AAA (20 vs. 6%), and both TAA and AAA (0 vs. 6%) (Figure 3C). The gene discussed is SDC1; the disease is triple-A syndrome.